Immunophenotypic Features of Childhood and Adult Acute Lymphoblastic Leukemia (ALL): Experience of the German Multicentre Trials ALL-BFM and GMALL

References

• Janossy G., Coustain-Smith E., Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 1989; 3: 170–181
   PubMed Web of Science ®Google Scholar
• Campana D., Hansen-Hagge T. E., Matutes E., et al. Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukemia. Leukemia 1990; 4: 620–624
   PubMed Web of Science ®Google Scholar
• Foon K. A., Todd R. F. immunologic classification of leukemia and lymphoma. Blood. 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Greaves M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986; 234: 697–704
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). Annals of Internal Medicine 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemias (AML-MO). British Journal of Haematology 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Campana D., Coustan-Smith E., Behm F. G. The definition of remission in acute leukemia with immunological techniques. Bone Marrow Transplantation 1991; 8: 429–437
   PubMed Web of Science ®Google Scholar
• Van Dongen J. J. M., Breit T. M., Adriaansen H. J., et al. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6(Suppl 1)47–59
   PubMed Web of Science ®Google Scholar
• Borowitz M. J. Immunologic markers in childhood acute lymphoblastic leukemia. Hematology/Oncology Clinics of North America 1990; 4: 743–765
   PubMed Web of Science ®Google Scholar
• Pui C. H., Crist W. M., Look A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449–1463
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Raghavachar A., Thiel E. Immunophenotypic classification of acute lymphoblastic leukemia. Bailliere's Clinical Haematology., (in press)
   PubMedGoogle Scholar
• Hoelzer D., Thiel E., Loffler H., et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–131
   PubMed Web of Science ®Google Scholar
• Thiel E., Kranz B. R., Raghavachar A., et al. Prethymic phenotype and genotype of pre-T (CD7+/ER−) cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73: 1247–1258
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Thiel E., Bartram C. R., . Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage. Acute Leukemias II. Prognostic Factors and Treatment Strategies, T. Buchner, G. Schellong, W. Hiddemann, J. Ritter, et al. Springer-Verlag, Heidelberg 1990; 419–427
   Google Scholar
• Ludwig W. D., Harbott J., Bartram C. R., . Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: Experience of the BFM study 86. Recent Advances in Cell Biology of Acute Leukemia Impact on Clinical Diagnosis and Therapy, W. D. Ludwig, E. Thiel, et al. Springer-Verlag, Berlin 1993; 269–282
   Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. The morphological classification of acute lymphoblastic leukaemia: Concordance among observers and clinical correlations. British Journal of Haematology 1981; 47: 553–561
   PubMed Web of Science ®Google Scholar
• Hoelzer D., Thiel E., Ludwig W. D., et al. The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 1992; 6(Suppl 2)175–177
   PubMedGoogle Scholar
• Reiter A., Schrappe M., Ludwig W. D., et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients, Results and conclusions of the multicenter trial ALL-BFM 86. (submitted for publication)
   Google Scholar
• Ludwig W. D., Bartram C. R., Ritter J., et al. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518–1528
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Bartram C. R., Harbott J., et al. Phenotypic and genotypic heterogeneity in infant acute leukemia I. Acute lymphoblastic leukemia. Leukemia 1989; 3: 431–439
   PubMed Web of Science ®Google Scholar
• Van der Does-van denBerg A., Bartram C. R., Basso G., et al. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) applied in the “BFM family” cooperative group. Medical and Pediatric Oncology 1992; 20: 497–505
   PubMedGoogle Scholar
• Ludwig W. D., Harbott J., Rieder H., . Incidence, biologic features and treatment outcome of myeloid-antigen-positive acute lymphoblastic leukemia (My + ALL). Acute Leukemias III. Prognostic Factors and Treatment Strategies, T. Buchner, W. Hiddemann, B. Wormann, G. Schellong, J. Ritter, et al. Springer-Verlag, Heidelberg, (in press)
   Google Scholar
• Sobol R. E., Royston I., Le Bien T. W., et al. Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 1985; 65: 730–735
   PubMed Web of Science ®Google Scholar
• Hussein K. K., Dahlberg S., Head D., et al. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance therapy. Blood 1989; 73: 57–63
   PubMed Web of Science ®Google Scholar
• Linker C. A., Levitt L. J., O'Donnell M., Forman S. J., Ries C. A. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 1991; 78: 2814–2822
   PubMed Web of Science ®Google Scholar
• Ellison R. R., Mick R., Cuttner J., et al. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult lymphocytic leukemia: A prospective randomized clinical trial by Cancer and Leukemia Group B. Journal of Clinical Oncology 1991; 9: 2002–2015
   PubMed Web of Science ®Google Scholar
• Foà R., Baldini L., Cattoretti G., et al. Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study. British Journal of Haematology 1985; 61: 251–259
   PubMed Web of Science ®Google Scholar
• Garand R., Vannier J. P., Béné M. C., et al. Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. Leukemia 1990; 4: 739–744
   PubMed Web of Science ®Google Scholar
• Van't Veer M. B., van Putten W. L. J., Verdonck L. F., et al. Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation. Annals of Hematology 1993; 66: 277–282
   PubMed Web of Science ®Google Scholar
• De Rossi G., Grossi C., Foà R., et al. Immunophenotype of acute lymphoblastic leukemia cells: The experience of the Italian Cooperative Group (Gimema). Leukemia and Lymphoma 1993; 9: 221–228
   PubMed Web of Science ®Google Scholar
• Verschuren M. C. M., Comans-Bitter W. M., Kapteijn C. A. C., et al. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 1993; 7: 1939–1947
   PubMed Web of Science ®Google Scholar
• Schwartz S., Buhring H. J., Busch F. W., et al. Differential expression of the c-kit protein product in hematopoietic malignancies. Annals of Hematology 1992; 65: A121
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Thiel E., Ludwig W. D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5: 637–645
   PubMed Web of Science ®Google Scholar
• Sobol R. E., Mick R., Royston I., et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New England Journal of Medicine 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Wiersma S. R., Ortega J., Sobel E., Weinberg K. I. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. New England Journal of Medicine 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Singh B., et al. Myeloid-as-sociated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198–202
   PubMed Web of Science ®Google Scholar
• Griesinger F., Elfers H., Ludwig W. D., et al. Six different HRX-FEL fusion transcripts in pre-pre-B ALL with and without cytogenetic demonstration of t(4;l I). Blood 1993; 82 (Suppl. 1): 36a
   Google Scholar